Novartis Investigative Site

Locarno 6600

0 studies enrolling now · 3 studies all time

What they study most

Epithelial Ovarian Cancer, Neoplasms, Breast, Renal Cell Carcinoma

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• HKT288 in Solid Tumors, Including Epithelial Ovarian Cancer and Renal Cell Carcinoma — Stopped early
• Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer — Completed